SCHEMBL8729044

SCHEMBL8729044

COc1ccc(C2CCOC2=O)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.48
ALDH1A1 P00352 1/20 0.47
PDE4A P27815 5/20 0.46
PDE4B Q07343 3/20 0.46
PDE4C Q08493 3/20 0.46
PDE4D Q08499 3/20 0.46
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PTAFR P25105 1/20 0.45
NR3C1 P04150 1/20 0.45
GFER P55789 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7905996 1.00 ACHE (0.48) ACHEALDH1A1PDE4APDE4BPDE4C
SCHEMBL2303850 0.79 DDB1 (0.50) ALDH1A1RAB9A
SCHEMBL7907475 0.79 DDB1 (0.50) ALDH1A1RAB9A
SCHEMBL28722327 0.77 DDB1 (0.55) ALDH1A1
SCHEMBL29100531 0.77 KCNH2 (0.57) ALDH1A1PTAFR
SCHEMBL30633820 0.77 KCNH2 (0.57) ALDH1A1PTAFR
SCHEMBL576857 0.73 CYP19A1 (0.45) ALDH1A1
SCHEMBL1823057 0.73 PTAFR (0.46) ACHEALDH1A1PDE4APDE4BPDE4C
SCHEMBL296803 0.72 SLC6A2 (0.43) RAB9A
SCHEMBL10158839 0.72 SLC6A2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0624584-B1 Piperazine derivatives useful as calmodulin inhibitors DAIICHI SEIYAKU CO (JP) 1998-08-19 EP disclosed
US-5681954-A HAS CALMODULIN INHIBITORY ACTIVITY; USEFUL IN TREATING DISEASES OF THE CIRCULATORY ORGANS OR IN CEREBRAL REGION DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-10-28 US disclosed
EP-0624584-A1 Piperazine derivatives useful as calmodolin inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1994-11-17 EP disclosed